Nuwellis (NUWE) EPS (Basic) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.21% |
| Dec 31, 2025 | 88.08% |
| Sep 30, 2025 | 17.81% |
| Jun 30, 2025 | -81.46% |
| Mar 31, 2025 | 43.07% |
| Dec 31, 2024 | -107.44% |
| Sep 30, 2024 | 27.97% |
| Jun 30, 2024 | -233.13% |
| Mar 31, 2024 | -16.02% |
| Dec 31, 2023 | 18.95% |
| Sep 30, 2023 | -49.40% |
| Jun 30, 2023 | -57.84% |
| Mar 31, 2023 | 17.55% |
| Dec 31, 2022 | 15.69% |
| Sep 30, 2022 | -51.84% |
| Jun 30, 2022 | -34.10% |
| Mar 31, 2022 | -3.91% |
| Dec 31, 2021 | -17.33% |
| Sep 30, 2021 | 63.62% |
| Jun 30, 2021 | 36.24% |
| Mar 31, 2021 | 27.01% |
| Dec 31, 2020 | 29.67% |
| Sep 30, 2020 | -42.02% |
| Jun 30, 2020 | -54.69% |
| Mar 31, 2020 | -95.90% |
| Dec 31, 2019 | 75.18% |
| Sep 30, 2019 | -169.44% |
| Jun 30, 2019 | -40.70% |
| Mar 31, 2019 | -97.68% |
| Dec 31, 2018 | -78.21% |
| Sep 30, 2018 | -78.43% |
| Jun 30, 2018 | -106.15% |
| Mar 31, 2018 | -100.21% |
| Dec 31, 2017 | -299.66% |
| Sep 30, 2017 | -61.05% |
| Jun 30, 2017 | -86.12% |
| Mar 31, 2017 | -121.32% |
| Dec 31, 2016 | -169.74% |
| Sep 30, 2016 | -168.70% |
| Jun 30, 2016 | -58.63% |
| Mar 31, 2016 | -70.05% |